©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 114076
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114076
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114076
Table 3 Limitations of mesenchymal stem cell therapy and main optimization strategies
| Limitations | Strategies | Functions |
| Low delivery efficiency | Biomaterials | Sustained release of MSCs, reduced degradation, preventing cell leakage, and prolonging retention at the injury site |
| Limited direct differentiation potential | Preconditioning/gene modification | Enhancing MSC differentiation towards bone, cartilage, tendon, and other tissues |
| Limited cell functionality | Preconditioning/gene modification | Boosting MSC proliferation, migration, angiogenesis, and immune modulation capabilities |
| Immunogenicity | Exosomes | Acellular therapies that eliminate cellular immunogenicity |
- Citation: Li H, Li ZP, Zhu MT, Lan CH, Wang YX, Liao P, Chen Z, Wang P, Sun JK, Shi Z, Lu PY, Lou C, Xu GH. Optimizing mesenchymal stem cell therapy for tendon-bone healing: Multifaceted approaches and future directions. World J Stem Cells 2025; 17(12): 114076
- URL: https://www.wjgnet.com/1948-0210/full/v17/i12/114076.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.114076